GGT and ALT are enzymes that leak into the blood when liver cells are stressed or damaged. Both function as general markers of liver and metabolic health, and both respond to the same two levers: alcohol intake and metabolic health. Their standard laboratory ranges are wide enough that a result can be flagged normal while sitting well above where the research suggests it is optimal.

A further category sits exactly where this page’s two levers overlap. MetALD describes people who meet MASLD criteria and also drink more than 140 grams of alcohol a week for women, or 210 grams for men. The 2023 consensus that retired the old terms introduced it precisely because alcohol and metabolic dysfunction so often travel together.

What the two enzymes measure

Both are enzymes that live inside liver cells and appear in the blood when those cells are stressed or damaged. Neither measures liver function directly. They measure leakage, which is a different and more indirect thing.

ALT, alanine aminotransferase, is relatively liver-specific, though it is also present in muscle, which is why hard training can raise it. GGT, gamma-glutamyl transferase, is found in the liver and bile ducts and is notably sensitive to alcohol, which is why it has long been used as an intake marker.

Their longevity relevance is mostly metabolic rather than hepatic. Fat accumulation in the liver is closely tied to insulin resistance and visceral fat, so these enzymes often move early in a metabolic problem that hasn’t yet shown up in glucose.

Optimised GGT and ALT against standard lab ranges

MarkerStandard lab rangeOptimised
GGT~5-50 U/LBelow 20-25
ALT~7-55 U/LBelow 25

Standard ranges vary between laboratories and often differ by sex, with lower upper limits for women. The optimised targets are consensus-based rather than guideline-derived.

This is the same pattern that appears with HbA1c and percentile benchmarking generally: the clinical range is built to detect disease, not to describe optimal. A GGT of 40 will be reported as normal and is roughly double where the optimized target sits.

Worth being clear about the strength of evidence. The optimized figures come from longevity-clinic consensus rather than a landmark trial, which puts them on weaker footing than the ACE body composition bands or the ADA glycemic thresholds cited elsewhere here. The Ruhl and Everhart citation does establish an association between both enzymes and mortality in a US population, so the direction of the relationship is evidenced even where the specific optimised cut-offs are not. Knowing that lower is better is not the same as knowing exactly where the line sits.

Where 'normal' ends and optimized begins
GGT and ALT optimized targets compared with standard laboratory ranges Standard laboratory ranges extend to about 50 units per liter for GGT and 55 for ALT. Optimised targets sit far lower, below 20 to 25 for GGT and below 25 for ALT, so a result can be reported as normal while sitting roughly double the optimized figure. GGT (U/L) optimized: below 20-25 still reported "normal" up to ~50 ALT (U/L) optimized: below 25 still reported "normal" up to ~55 Clinical ranges are built to detect disease, not to describe optimal. A GGT of 40 will come back flagged as normal, and is roughly double the optimized target. The optimized figures come from longevity-clinic consensus, not a landmark trial. Weaker footing than most thresholds here.
Standard ranges vary between laboratories and often differ by sex. Optimised targets are consensus-based rather than guideline-derived.

Why GGT and ALT are scored as a pair

Longevity Coach IQ scores GGT and ALT with the same formula, the same source citation and the same framing, so presenting them as two separate entries would suggest a distinction the evidence doesn’t carry.

They aren’t identical. GGT is more alcohol-sensitive and also rises with bile duct problems; ALT is more specific to liver cell damage. But as general markers of liver and metabolic stress, in the context of a longevity score rather than a diagnostic workup, they answer the same question and respond to the same interventions.

The same reasoning is why ApoB and LDL cholesterol share an entry.

GGT interpreter

Optimised targets sit well below what a laboratory reports as normal.

ALT interpreter

Same pattern as GGT. Recent hard training can raise ALT without any liver involvement.

What raises GGT and ALT

  • Alcohol. The most direct cause, particularly for GGT. Effects appear quickly and resolve quickly.
  • Fatty liver. MASLD affects an estimated 25 to 38 percent of the general population globally and is the most common reason for a mildly raised ALT. It travels with insulin resistance and visceral fat.
  • Recent hard training. ALT is present in muscle, so a heavy session in the days before a test can raise it without any liver involvement at all.
  • Medications. Several common drugs affect liver enzymes, including statins and paracetamol at higher doses.
  • Viral hepatitis and other liver disease. Less common, and the reason a persistently high result belongs with a doctor rather than a training plan.

How to lower GGT and ALT

Two levers do most of the work, and they are the same two for both enzymes: reduce alcohol intake, and improve metabolic health through weight loss, less added sugar and regular exercise.

These markers respond relatively quickly, often within eight to twelve weeks, which makes them a useful confirmation that a metabolic intervention is doing something.

Where the improvement estimate comes from. The roughly 10 percent threshold used for a meaningful response is drawn from a 12-week pediatric lifestyle-intervention study, applied as a conservative adult estimate because a directly sourced adult figure wasn’t found. The app flags this in its own source citation, and it is repeated here rather than smoothed over: it is the weakest sourcing behind any projection in the system.

When a liver enzyme result needs a doctor

Mild elevations are common and usually metabolic. Certain patterns aren’t, and are worth raising rather than training around: values several times the upper limit, a result that keeps climbing across repeat tests, or enzymes elevated alongside jaundice, abdominal pain or unexplained fatigue.

A very high GGT with a normal ALT points toward the bile ducts rather than liver cells, which is a different investigation. Interpreting these patterns is a clinical task, and this entry isn’t a substitute for one.

Where GGT and ALT fit in a plan

Both enzymes sit in Systemic Health in the Complete tracking mode. Unlike Lp(a) and cystatin C, they are included in projections, because they genuinely do respond to habits within a realistic timeframe.

Read them as metabolic markers rather than liver markers. Elevated levels in someone who drinks little are usually pointing at visceral fat and insulin resistance, which means the work is the same work that moves triglycerides and waist-to-height ratio.

Sources

Key references for the claims on this page. Where a figure is attributed to a specific study or body, it is named here.

  1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 2023;78(6):1966–1986. The consensus that retired NAFLD and NASH in favour of MASLD, MASH and MetALD. DOI
  2. Longevity-clinic consensus rather than a single landmark trial: optimal GGT below 20 to 25 U/L against a standard laboratory range of roughly 5 to 50, and optimal ALT below 25 U/L against a standard range of roughly 7 to 55.
  3. Honesty note: the roughly 10 percent improvement threshold Longevity Coach IQ uses for meaningful response comes from a 12-week paediatric lifestyle-intervention study. It is applied here as a conservative adult estimate because a directly sourced adult figure wasn’t found. That is a genuine limitation of the projection for these two markers.
  4. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology, 2009;136(2):477–485. DOI Association of both enzymes with mortality.
  5. MASLD affects an estimated 25 to 38 percent of the general population globally and is strongly associated with insulin resistance and visceral adiposity.

Frequently asked

What is a good GGT level?

Optimised is below 20 to 25 U/L. Standard laboratory ranges extend to around 50, so a result of 40 is typically reported as normal while sitting well above where the research suggests it is ideal.

What is a good ALT level?

Optimised is below 25 U/L, against a standard upper limit around 55. Reference ranges also differ by sex in many laboratories, with lower upper limits for women.

Why does the app treat GGT and ALT the same?

They respond to the same levers, carry similar interpretations as general liver and metabolic stress markers, and share the same evidence base for improvement. Scoring them separately would imply a distinction the underlying evidence doesn’t support.

Does alcohol raise both?

GGT is the more alcohol-sensitive of the two and has historically been used as a marker of alcohol intake. ALT responds as well but less specifically. Both fall when intake drops, GGT typically faster.

Can high liver enzymes be normal for me?

Mildly elevated results are common and have many causes, including recent intense exercise, which raises ALT because it is present in muscle too. A single elevated reading is a reason to retest under better conditions rather than to conclude anything.

What is fatty liver and do these detect it?

MASLD is fat accumulation in the liver, strongly tied to insulin resistance and visceral fat. Elevated ALT is a common signal, but enzymes can be normal despite significant fat accumulation, so normal results don’t exclude it. Imaging is the reliable test.

How quickly do they respond?

Faster than most markers here. Meaningful changes can appear within eight to twelve weeks of reduced alcohol intake and weight loss, which makes them useful for confirming that a metabolic intervention is working.

Should I take supplements for liver health?

Milk thistle and similar products have weak evidence for changing outcomes. The levers with actual support are unglamorous: less alcohol, less visceral fat, better glycemic control.